Article metrics

Download PDFPDF

698 A phase 2 study of durvalumab combined with chemotherapy and stereotactic body radiotherapy (SBRT) in patients with oligometastatic non-small cell lung cancer (NSCLC) (SABRCURE trial)
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to January 2024

AbstractFullPdf
Nov 2022228014
Dec 20224403
Jan 20235204
Feb 20232405
Mar 20233804
Apr 20232204
May 20239203
Jun 20231803
Jul 20231204
Aug 20231403
Sep 20231200
Oct 20233604
Nov 20232404
Dec 20235204
Jan 20242005
Total688064